OtherArticle
In vitro and in vivo metabolism of a novel antimitochondrial cancer metabolism agent, CPI-613, in rats and human
Vijay Reddy, Lakmal Boteju, Asela Boteju, Li Shen, Kelem Kassahun, Nageshwar Reddy, Adrian Sheldon, Sanjeev Luther and Ke Hu
Drug Metabolism and Disposition January 27, 2022, DMD-AR-2021-000726; DOI: https://doi.org/10.1124/dmd.121.000726
Vijay Reddy
1
Lakmal Boteju
2Rafael Pharmaceuticals Inc, United States
Asela Boteju
3Rafael Pharmaceuticals Inc., United States
Li Shen
4Frontage Laboratories Inc., United States
Kelem Kassahun
4Frontage Laboratories Inc., United States
Nageshwar Reddy
3Rafael Pharmaceuticals Inc., United States
Adrian Sheldon
5Charles River Laboratories Inc., United States
Sanjeev Luther
3Rafael Pharmaceuticals Inc., United States
Ke Hu
3Rafael Pharmaceuticals Inc., United States
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherArticle
β-Oxidation of CPI-613 in rats and human
Vijay Reddy, Lakmal Boteju, Asela Boteju, Li Shen, Kelem Kassahun, Nageshwar Reddy, Adrian Sheldon, Sanjeev Luther and Ke Hu
Drug Metabolism and Disposition January 27, 2022, DMD-AR-2021-000726; DOI: https://doi.org/10.1124/dmd.121.000726
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement